NG
PDLI

NatWest Group’s PDL BioPharma, Inc. PDLI Stock Holding History

NatWest Group’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-91,069
Closed -$458K – 402
2015
Q3 		$458K Buy
+91,069
New +$522K 0.01% 291
2015
Q2 		– Sell
-91,069
Closed -$641K – 459
2015
Q1 		$641K Buy
91,069
+20,444
+29% +$148K 0.01% 283
2014
Q4 		$545 Buy
70,625
+34,420
+95% +$272K ﹤0.01% 299
2014
Q3 		$270 Hold
36,205
– – ﹤0.01% 450
2014
Q2 		$350K Sell
36,205
-9,788
-21% -$87.2K 0.01% 410
2014
Q1 		$382K Sell
45,993
-1,536
-3% -$13.2K 0.02% 380
2013
Q4 		$401K Sell
47,529
-16,514
-26% -$139K 0.01% 605
2013
Q3 		$510K Buy
64,043
+5,117
+9% +$41.1K 0.01% 704
2013
Q2 		$455K Buy
+58,926
New +$459K 0.01% 616

Other funds holding PDLI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return